On the other hand, in vitro studies often describe that targeted IFITM1, IFITM2 and IFITM3 protein silencing in cancer cells causes proliferation inhibition, cell cycle arrest and senescence (15, 17, 150, 154, 157, 161, 167). Here, IFITM2 is linked to cancer.